| The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases S Krasemann, C Madore, R Cialic, C Baufeld, N Calcagno, R El Fatimy, ... Immunity 47 (3), 566-581. e9, 2017 | 2143 | 2017 |
| Loss of ‘homeostatic’microglia and patterns of their activation in active multiple sclerosis T Zrzavy, S Hametner, I Wimmer, O Butovsky, HL Weiner, H Lassmann Brain 140 (7), 1900-1913, 2017 | 624 | 2017 |
| The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain L Haider, T Zrzavy, S Hametner, R Höftberger, F Bagnato, G Grabner, ... Brain 139 (3), 807-815, 2016 | 436 | 2016 |
| Disease-specific molecular events in cortical multiple sclerosis lesions MT Fischer, I Wimmer, R Höftberger, S Gerlach, L Haider, T Zrzavy, ... Brain 136 (6), 1799-1815, 2013 | 337 | 2013 |
| Acute and non-resolving inflammation associate with oxidative injury after human spinal cord injury T Zrzavy, C Schwaiger, I Wimmer, T Berger, J Bauer, O Butovsky, ... Brain 144 (1), 144-161, 2021 | 124 | 2021 |
| Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients S Jarius, C Lechner, EM Wendel, M Baumann, M Breu, M Schimmel, ... Journal of neuroinflammation 17 (1), 1-28, 2020 | 117 | 2020 |
| Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts T Zrzavy, J Machado‐Santos, S Christine, C Baumgartner, HL Weiner, ... Brain Pathology 28 (6), 791-805, 2018 | 109 | 2018 |
| Pro‐inflammatory activation of microglia in the brain of patients with sepsis T Zrzavy, R Höftberger, T Berger, H Rauschka, O Butovsky, H Weiner, ... Neuropathology and applied neurobiology 45 (3), 278-290, 2019 | 101 | 2019 |
| Interleukin-6 receptor blockade in treatment-refractory MOG-IgG–associated disease and neuromyelitis optica spectrum disorders M Ringelstein, I Ayzenberg, G Lindenblatt, K Fischer, A Gahlen, G Novi, ... Neurology: Neuroimmunology & Neuroinflammation 9 (1), e1100, 2021 | 94 | 2021 |
| Vaccination in multiple sclerosis: friend or foe? T Zrzavy, H Kollaritsch, PS Rommer, N Boxberger, M Loebermann, ... Frontiers in Immunology 10, 1883, 2019 | 93 | 2019 |
| Neuroinflammatory responses in experimental and human stroke lesions I Wimmer, T Zrzavy, H Lassmann Journal of neuroimmunology 323, 10-18, 2018 | 67 | 2018 |
| Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease C Vilariño-Güell, A Zimprich, F Martinelli-Boneschi, B Herculano, Z Wang, ... PLoS genetics 15 (6), e1008180, 2019 | 59 | 2019 |
| Neuropathological Variability within a Spectrum of NMDAR‐Encephalitis T Zrzavy, V Endmayr, J Bauer, S Macher, N Mossaheb, C Schwaiger, ... Annals of neurology 90 (5), 725-737, 2021 | 51 | 2021 |
| Vaccination and multiple sclerosis in the era of the COVID-19 pandemic T Monschein, HP Hartung, T Zrzavy, M Barnett, N Boxberger, T Berger, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (10), 1033-1043, 2021 | 41 | 2021 |
| Longitudinal retinal changes in MOGAD FC Oertel, ES Sotirchos, HG Zimmermann, S Motamedi, S Specovius, ... Annals of Neurology 92 (3), 476-485, 2022 | 33 | 2022 |
| Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score G Bsteh, H Hegen, K Riedl, P Altmann, M Auer, K Berek, F Di Pauli, ... European Journal of Neurology 28 (5), 1609-1616, 2021 | 30 | 2021 |
| COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry G Bsteh, H Assar, H Hegen, B Heschl, F Leutmezer, F Di Pauli, C Gradl, ... PloS one 16 (7), e0255316, 2021 | 29 | 2021 |
| Immunology of COVID‐19 and disease‐modifying therapies: the good, the bad and the unknown T Zrzavy, I Wimmer, PS Rommer, T Berger European Journal of Neurology, 2020 | 25 | 2020 |
| Longitudinal CSF Findings in Autoimmune Encephalitis—A Monocentric Cohort Study T Zrzavy, R Höftberger, I Wimmer, T Berger, P Rommer, S Macher Frontiers in Immunology 12, 741, 2021 | 24 | 2021 |
| Evaluation of retinal layer thickness parameters as biomarkers in a real-world multiple sclerosis cohort N Schurz, L Sariaslani, P Altmann, F Leutmezer, C Mitsch, B Pemp, ... Eye and Brain, 59-69, 2021 | 21 | 2021 |
